Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis.
Wu P, Zhang C, Tang X, Li D, Zhang G, Zi X, Liu J, Yin E, Zhao J, Wang P, Wang L, Li R, Wu Y, Sun N, He J.
Wu P, et al. Among authors: li d, li r.
Mol Cancer. 2024 Feb 12;23(1):31. doi: 10.1186/s12943-023-01915-7.
Mol Cancer. 2024.
PMID: 38347558
Free PMC article.